...
...
Next Story
Trending News

AstraZeneca Covid-19 vaccine booster shot effective against Omicron: Oxford lab study

The study found that antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from Covid-19.

Published on: Dec 23, 2021, 13:19:16 IST
Reuters |
Advertisement

A three-dose course of AstraZeneca's Covid-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.

The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, US.  (REUTERS)
The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, US.  (REUTERS)

The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from Covid-19.

Suggested For You

After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus's Delta variant after two doses, the company added.

The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.

 

Explore More

Get the latest World News, breaking headlines, and real-time coverage from key global hotspots, including the US News, Russia, Ukraine, Iran News, and the UAE News. Track developing conflicts, high-stakes diplomacy, and major international events on Hindustan Times.
Get the latest World News, breaking headlines, and real-time coverage from key global hotspots, including the US News, Russia, Ukraine, Iran News, and the UAE News. Track developing conflicts, high-stakes diplomacy, and major international events on Hindustan Times.
SHARE THIS ARTICLE ON
Notifications

Get breaking alerts directly from the newsroom

Notifications are on!You'll be notified when news breaks